Abstracts tagged "fractures and osteoporosis"

Abstract Number: 2253 • 2014 ACR/ARHP Annual Meeting
Effect of Teriparatide in Patients with Osteoporosis with Prior Vertebral Fracture
Guillermo Valenzuela¹, Douglas Yim², Douglas Beall³, Michael Gordon⁴, John H. Krege⁵ and Kelly D. Krohn⁶, ¹Integral Rheumatology and Immunology Specialists, Plantation, FL, ²Division of Vascular & Interventional Radiology, University of California, Irvine Medical Center, Orange, California, Orange, CA, ³Clinical Radiology of Oklahoma, Edmond, Oklahoma, Edmonda, OK, ⁴Newport Orthopedic Institute, Newport Beach, California, Newport Beach, CA, ⁵Eli Lilly and Company, LLC, Indianapolis, Indiana, Indianapolis, IN, ⁶DC 5208, Eli Lilly and Company, LLC, Indianapolis, Indiana, Indianapolis, IN
Background/Purpose: The Direct Assessment of Nonvertebral Fracture in Community Experience (DANCE) study was an open-label, prospective, observational study that examined occurrence of nonvertebral fragility fractures…
Abstract Number: 2105 • 2014 ACR/ARHP Annual Meeting
Nonsurgical Treatment Patterns in Patients with Chronic Spinal Cord Injury
Brian Le¹, Monique Bethel², Lauren Bailey³, Frances Weaver³, Stephen Burns⁴, Jelena Svircev⁴, Michael Heggeness⁵ and Laura Carbone⁶, ¹Medicine, Georgia Regents University, Augusta, GA, ²Internal Medicine, Georgia Regents University, Augusta, GA, ³Edward Hines Jr. VA Hospital, Chicago, IL, ⁴VA Puget Sound Healthcare System, Seattle, WA, ⁵Orthopaedic Surgery, University of Kansas School of Medicine, Kansas City, KS, ⁶Medicine, Charlie Norwood VA Medical Center, Augusta, GA
Background/Purpose: Sublesional loss of bone mineral density is a common complication in patients with chronic spinal cord injury (SCI) putting them at high risk for…
Abstract Number: 51 • 2014 ACR/ARHP Annual Meeting
High Incidence of Non-Vertebral Osteoporotic Fracture and Hip Fracture in Brazilian Low-Income Community-Dwelling Elderly: A Population-Based Prospective Cohort Analysis from the São Paulo Ageing & Health (SPAH) Study
Diogo S. Domiciano¹, Luana G. Machado², Jaqueline B. Lopes², Camille P. Figueiredo², Valéria Caparbo², Liliam Takayama², Ricardo Oliveira³, Paulo R Menezes⁴ and Rosa M. R. Pereira⁵, ¹Rheumatology, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³RDO Diagnósticos Médicos, São Paulo, Brazil, ⁴Preventive Medicine, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ⁵Reumatologia, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil
Background/Purpose: There is considerable variability in the incidence of hip fracture among countries, even among different geographical areas within the same country. In Brazil, population…
Abstract Number: 1236 • 2013 ACR/ARHP Annual Meeting
Outcomes and Costs Of Sacral Insufficiency Fractures
Shahryar Hadavi¹, Sanam Kia¹, Christian Dejaco², Bhaskar Dasgupta² and Frances Borg³, ¹Rheumatology Department, Southend University Hospital, Westcliff-on-Sea, United Kingdom, ²Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom, ³Rheumatology, Southend University Hospital, Westcliff-on-sea, United Kingdom
Background/Purpose: Sacral insufficiency fracture (SIF) is a poorly recognised cause of lower back pain in the elderly with significant potential morbidity. Diagnosis is often slow…
Abstract Number: 1979 • 2012 ACR/ARHP Annual Meeting
Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center
Arthur N. Lau¹, Michael Branch², Robert Bensen³, Jonathan D. Adachi⁴, Alexandra Papaioannou⁵, William Wong-Pack⁶ and William G. Bensen⁷, ¹Rheumatology and Clinical Epidemiology, Division of Rheumatology, McMaster University, Hamilton, ON, Canada, ²CEO, Inovex, Oakville, ON, Canada, ³Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ⁴St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, ⁵Geriatric Medicine, McMaster University, Hamilton, ON, Canada, ⁶Department Of Nuclear Medicine, Hamilton, ON, Canada, ⁷Department of Medicine, Division of Rheumatology, St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada
Background/Purpose: A number of clinical prediction tools are available to stratify patients into low, moderate and high risk for fractures in future. These tools are…
Abstract Number: 1983 • 2012 ACR/ARHP Annual Meeting
Comparative Risk of Fracture in Men and Women with Human Immunodeficiency Virus
Lydia Gedmintas¹, Elizabeth Wright², Jeffrey N. Katz³, Elena Losina⁴ and Daniel H. Solomon⁵, ¹Rheumatology, Brigham's Women's Hospital, Boston, MA, ²Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ⁴Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ⁵Division of Rheumatology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: A growing body of evidence suggests that HIV-positive patients have an increased risk of osteoporosis compared to HIV-negative patients, with some studies suggesting a…
Abstract Number: 1987 • 2012 ACR/ARHP Annual Meeting
A Comparison of Unilateral and Bilateral Hip BMD
Steven C. Schaub¹, Edward S. Leib² and Diantha Howard³, ¹Medical School, U of Vermont College of Med, Burlington, VT, ²Medicine, U of Vermont College of Med, Burlington, VT, ³Statistics, Vermont Center for Clinical and Translational Science, Burlington, VT
Background/Purpose: The utility of bilateral hip dual energy x-ray absorptiometry scanning for identifying low bone mineral density has been a cause of debate. Intraperson differences…
Abstract Number: 1998 • 2012 ACR/ARHP Annual Meeting
Relationship Between Changes in Bone Mineral Density and Incidence of Fracture with 6 Years of Denosumab Treatment
Michael A. Bolognese¹, Paul D. Miller², Jean-Yves Reginster³, Nathalie Franchimont⁴, Gerolamo Bianchi⁵, Roland Chapurlat⁶, Federico G. Hawkins⁷, David L. Kendler⁸, Beatriz Oliveri⁹, Jose R. Zanchetta¹⁰, Nadia Daizadeh⁴, Andrea Wang⁴, Rachel B. Wagman⁴ and Socrates Papapoulos¹¹, ¹Bethesda Health Research Center, Bethesda, MD, ²University of Colorado Health Sciences Center and Colorado Center for Bone Research, Lakewood, CO, ³Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ⁴Amgen Inc., Thousand Oaks, CA, ⁵LELICOMAR - Div Reumatologia, Azienda Sanitaria Genovese, Genoa, Italy, ⁶Hôpital Edouard Herriot, Lyon, France, ⁷Hospital Universitario, Madrid, Spain, ⁸University of British Columbia, Vancouver, BC, Canada, ⁹Laboratorio Enfermedades Metabólicas Oseas, Hospital de Clínicas, INIGEM UBA-CONICET, Buenos Aires, Argentina, ¹⁰Instituto de Investigaciones Metabólicas and University of Salvador, Buenos Aires, Argentina, ¹¹Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: During the first 3 years of denosumab treatment in FREEDOM, there were continued increases in bone mineral density (BMD) and a robust reduction in…
Abstract Number: 1966 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness of Bazedoxifene Compared with Raloxifene in the Treatment of Postmenopausal Osteoporotic Women
Mickaël Hiligsmann¹, Wafa Ben Sedrine¹ and J.-Y. Reginster², ¹Department of Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium, ²Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
Background/Purpose: Bazedoxifene is a novel selective estrogen receptor modulator (SERM) in development for the prevention and treatment of osteoporosis. In addition to the therapeutic value…
Abstract Number: 1974 • 2012 ACR/ARHP Annual Meeting
Incidence of Atypical Femur Fractures Associated with Bisphosphonate Use for Osteoporosis: A Systematic Review of the Literature
John N. Mecchella¹, John A. Batsis², Robin J. Larson³ and Gautham Suresh⁴, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²General Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, ³The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, ⁴Neonatology, Pediatrics, Dartmouth Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Reports of a link between bisphosphonate use in patients with osteoporosis and atypical femoral fractures--those occurring in subtrochanteric or diaphyseal locations--have generated significant concern…
Abstract Number: 922 • 2012 ACR/ARHP Annual Meeting
Risk of Fracture Among Treated and Untreated Men with Osteoporosis
Karen Tomic¹, Joanne Lafleur², Liisa Palmer¹, David M. Smith¹, Carly J. Paoli³, Irene Agodoa³ and Nicole Yurgin³, ¹Truven Health Analytics, Washington, DC, ²University of Utah College of Pharmacy, Salt Lake City, UT, ³Amgen Inc, Thousand Oaks, CA
Background/Purpose: Osteoporosis (OP) affects an estimated 2 million men in the United States. The relationship between treatment and fracture outcomes has been reported from clinical…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].